ArticleFrontiers in immunology2023
Protective anti-tumor vaccination against glioblastoma expressing the MHC class II transactivator CIITA.
Fabrizio Celesti et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it